Sunday, February 8, 2026

Latest

Starbucks: Analyst Consensus Estimates

Starbucks (NASDAQ: SBUX) will be reporting their fiscal second quarter financial results today after the close of markets. Analysts have a consensus $115.05 12-month price target on the company, via a total of 34 analysts, with ten analysts having strong buy ratings. Nine analysts meanwhile have buy ratings and 15 have hold ratings. The street high is a $137 price target, and the lowest target sits at $82.

24 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 24 analysts is $6.8 billion; this number has been revised upwards from $6.7 billion at the start of the year. The highest revenue estimate is $7.47 billion, while the lowest is $6.5 billion.

Onto EBITDA estimates, there are currently 17 analysts who have second-quarter EBITDA estimates. The mean is currently $1.27 billion, with this number having been revised down from $1.35 billion at the start of the year. The street high estimate currently sits at $1.36 billion in EBITDA and the lowest is $1.17 billion.

Analysts estimate that quarterly earnings per share will come in at $0.52, with this number being slightly revised down from $0.59 at the start of the year. Street high currently sits at $0.59 in earnings per share, while the lowest estimate is $0.47 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold Prices Are High, Experience Matters | Rob McLeod

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Is This the End of the Gold and Silver Rally? | Peter Grandich

Recommended

TomaGold Confirms Presence Of Berrigan Deep Zone Following Geophysics

Antimony Resources Reports Massive Stibnite Mineralization Over 25 Metres At Marcus (West) Zone

Related News

Stifel Raises Eguana Technologies Price Target To $0.90

Yesterday Stifel GMP raised their price target on Eguana Technologies (TSXV: EGT) from C$0.85 to...

Thursday, May 6, 2021, 04:21:00 PM

Canaccord: 2020 To Be Transition Year For Medipharm Labs

Last week, Medipharm Labs (TSX: LABS) reported their second-quarter earnings. Revenue came in at $13.9...

Saturday, August 22, 2020, 01:38:00 PM

Aphria: Canaccord Anticipates Q2 2021 Revenue Of $156.3 Million

Aphria Inc (TSX: APHA) (NASDAQ: APHA) will be releasing their second-quarter fiscal 2021 financial results...

Tuesday, January 12, 2021, 11:57:00 AM

Mind Medicine: Canaccord Genuity Initiates Coverage With C$1.75 Price Target

Yesterday, Canaccord initiated coverage on Mind Medicine (NEO: MMED) with a Speculative Buy rating and...

Wednesday, September 16, 2020, 04:15:00 PM

McDonalds: BMO Upgrades Firm Off Back Of Strong Earnings

On July 28, McDonald’s Corp (NYSE: MCD) reported their second quarter financial results. The company...

Sunday, August 1, 2021, 04:16:00 PM